{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:02:40Z","timestamp":1791910960851,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Azad","award":["16330520952001"],"award-info":[{"award-number":["16330520952001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s12012-021-09685-8","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T07:03:31Z","timestamp":1627887811000},"page":"936-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study"],"prefix":"10.1007","volume":"21","author":[{"given":"Maryam","family":"Rahmanifard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Vessal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Noorafshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-1730","authenticated-orcid":false,"given":"Saied","family":"Karbalay-Doust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-5175","authenticated-orcid":false,"given":"Maryam","family":"Naseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"9685_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4172\/2157-7439.1000519","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao, N., Woodle, M. C., & Mixson, A. J. (2018). Advances in delivery systems for doxorubicin. Journal of Nanomedicine & Nanotechnology, 9, 10. https:\/\/doi.org\/10.4172\/2157-7439.1000519","journal-title":"Journal of Nanomedicine & Nanotechnology"},{"key":"9685_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000265166","volume":"115","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S. (2010). Doxorubicin cardiomyopathy. Cardiology, 115, 155\u2013162.","journal-title":"Cardiology"},{"key":"9685_CR3","first-page":"1132","volume":"11","author":"TW Mudd Jr","year":"2021","unstructured":"Mudd, T. W., Jr., Khalid, M., & Guddati, A. K. (2021). Cardiotoxicity of chemotherapy and targeted agents. American Journal of Cancer Research, 11, 1132.","journal-title":"American Journal of Cancer Research"},{"key":"9685_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tips.2015.03.005","volume":"36","author":"L Rochette","year":"2015","unstructured":"Rochette, L., Guenancia, C., Gudjoncik, A., Hachet, O., Zeller, M., Cottin, Y., & Vergely, C. (2015). Anthracyclines\/trastuzumab: New aspects of cardiotoxicity and molecular mechanisms. Trends in Pharmacological Sciences, 36, 326\u2013348.","journal-title":"Trends in Pharmacological Sciences"},{"key":"9685_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","volume":"49","author":"G Takemura","year":"2007","unstructured":"Takemura, G., & Fujiwara, H. (2007). Doxorubicin-induced cardiomyopathy: From the cardiotoxic mechanisms to management. Progress in Cardiovascular Diseases, 49, 330\u2013352.","journal-title":"Progress in Cardiovascular Diseases"},{"key":"9685_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/JAHA.120.018802","volume":"10","author":"P Jeyaprakash","year":"2021","unstructured":"Jeyaprakash, P., Sangha, S., Ellenberger, K., Sivapathan, S., Pathan, F., & Negishi, K. (2021). Cardiotoxic effect of modern anthracycline dosing on left ventricular ejection fraction: A systematic review and meta-analysis of placebo arms from randomized controlled trials. Journal of the American Heart Association, 10, 188.","journal-title":"Journal of the American Heart Association"},{"key":"9685_CR7","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1152\/ajpendo.00044.2013","volume":"305","author":"VW Dolinsky","year":"2013","unstructured":"Dolinsky, V. W., Rogan, K. J., Sung, M. M., Zordoky, B. N., Haykowsky, M. J., Young, M. E., Jones, L. W., & Dyck, J. R. (2013). Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. American Journal of Physiology-Endocrinology and Metabolism, 305, E243\u2013E253.","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"9685_CR8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. (2012). Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nature Medicine, 18, 1639\u20131642.","journal-title":"Nature Medicine"},{"key":"9685_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12012-019-09547-4","volume":"20","author":"AFM Botelho","year":"2019","unstructured":"Botelho, A. F. M., Lempek, M. R., Branco, S. E. M., Nogueira, M. M., de Almeida, M. E., Costa, A. G., Freitas, T. G., Rocha, M. C. R., Moreira, M. V., & Barreto, T. O. (2019). Coenzyme Q10 cardioprotective effects against doxorubicin-induced cardiotoxicity in Wistar rat. Cardiovascular Toxicology, 20, 222.","journal-title":"Cardiovascular Toxicology"},{"key":"9685_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/tox.22270","volume":"32","author":"PY Chen","year":"2017","unstructured":"Chen, P. Y., Hou, C. W., Shibu, M. A., Day, C. H., Pai, P., Liu, Z. R., Lin, T. Y., Viswanadha, V. P., Kuo, C. H., & Huang, C. Y. (2017). Protective effect of Co-enzyme Q10 on doxorubicin-induced cardiomyopathy of rat hearts. Environmental Toxicology, 32, 679\u2013689.","journal-title":"Environmental Toxicology"},{"key":"9685_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/1534735405276191","volume":"4","author":"KA Conklin","year":"2005","unstructured":"Conklin, K. A. (2005). Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integrative Cancer Therapies, 4, 110\u2013130.","journal-title":"Integrative Cancer Therapies"},{"key":"9685_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008684.pub2","author":"ME Madmani","year":"2014","unstructured":"Madmani, M. E., Solaiman, A. Y., Agha, K. T., Madmani, Y., Shahrour, Y., Essali, A., & Kadro, W. (2014). Coenzyme Q10 for heart failure. Cochrane Database of Systematic Reviews. https:\/\/doi.org\/10.1002\/14651858.CD008684.pub2","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"9685_CR13","first-page":"299","volume":"46","author":"R Singh","year":"1998","unstructured":"Singh, R., Niaz, M., Rastogi, V., & Rastogi, S. (1998). Coenzyme Q in cardiovascular disease. The Journal of the Association of Physicians of India, 46, 299\u2013306.","journal-title":"The Journal of the Association of Physicians of India"},{"key":"9685_CR14","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1200\/JCO.2004.02.034","volume":"22","author":"L Roffe","year":"2004","unstructured":"Roffe, L., Schmidt, K., & Ernst, E. (2004). Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: A systematic review. Journal of Clinical Oncology, 22, 4418\u20134424.","journal-title":"Journal of Clinical Oncology"},{"key":"9685_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1534735415610427","volume":"15","author":"A Yasueda","year":"2016","unstructured":"Yasueda, A., Urushima, H., & Ito, T. (2016). Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: A systematic review. Integrative Cancer Therapies, 15, 17\u201339.","journal-title":"Integrative Cancer Therapies"},{"key":"9685_CR16","first-page":"158","volume":"49","author":"M Miedziaszczyk","year":"2021","unstructured":"Miedziaszczyk, M., Cie\u015blewicz, A., & Jab\u0142ecka, A. (2021). Efficacy of coenzyme Q10 in supportive therapy of the cardiovascular diseases and in the prevention of cardiotoxicity caused by chemotherapy. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego, 49, 158\u2013161.","journal-title":"Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego"},{"key":"9685_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/15353702-0322805-14","volume":"228","author":"ML Genova","year":"2003","unstructured":"Genova, M. L., Pich, M. M., Biondi, A., Bernacchia, A., Falasca, A., Bovina, C., Formiggini, G., Castelli, G. P., & Lenaz, G. (2003). Mitochondrial production of oxygen radical species and the role of Coenzyme Q as an antioxidant. Experimental Biology and Medicine, 228, 506\u2013513.","journal-title":"Experimental Biology and Medicine"},{"key":"9685_CR18","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.mito.2007.02.006","volume":"7","author":"M Bentinger","year":"2007","unstructured":"Bentinger, M., Brismar, K., & Dallner, G. (2007). The antioxidant role of coenzyme Q. Mitochondrion, 7, S41\u2013S50.","journal-title":"Mitochondrion"},{"key":"9685_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","volume":"14","author":"J Hartupee","year":"2017","unstructured":"Hartupee, J., & Mann, D. L. (2017). Neurohormonal activation in heart failure with reduced ejection fraction. Nature Reviews Cardiology, 14, 30\u201338.","journal-title":"Nature Reviews Cardiology"},{"key":"9685_CR20","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","volume":"111","author":"DL Mann","year":"2005","unstructured":"Mann, D. L., & Bristow, M. R. (2005). Mechanisms and models in heart failure: The biomechanical model and beyond. Circulation, 111, 2837\u20132849.","journal-title":"Circulation"},{"key":"9685_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s004310051294","volume":"159","author":"M Hauser","year":"2000","unstructured":"Hauser, M., & Wilson, N. (2000). Anthracycline induced cardiomyopathy: Successful treatment with angiotensin converting enzyme inhibitors. European Journal of Pediatrics, 159, 389.","journal-title":"European Journal of Pediatrics"},{"key":"9685_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/cvr\/cvx162","volume":"114","author":"R Hullin","year":"2018","unstructured":"Hullin, R., M\u00e9trich, M., Sarre, A., Basquin, D., Maillard, M., Regamey, J., & Martin, D. (2018). Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity. Cardiovascular Research, 114, 272\u2013281.","journal-title":"Cardiovascular Research"},{"key":"9685_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1385\/CT:3:4:319","volume":"3","author":"RJ Boucek","year":"2003","unstructured":"Boucek, R. J., Steele, A., Miracle, A., & Atkinson, J. (2003). Effects of angiotensin-converting enzyme inhibitor on delayed-onset doxorubicin-induced cardiotoxicity. Cardiovascular Toxicology, 3, 319\u2013329.","journal-title":"Cardiovascular Toxicology"},{"key":"9685_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.vph.2009.01.001","volume":"50","author":"G Sacco","year":"2009","unstructured":"Sacco, G., Bigioni, M., Lopez, G., Evangelista, S., Manzini, S., & Maggi, C. A. (2009). ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Vascular Pharmacology, 50, 166\u2013170.","journal-title":"Vascular Pharmacology"},{"key":"9685_CR25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/0976-500X.103704","volume":"3","author":"S Parasuraman","year":"2012","unstructured":"Parasuraman, S., & Raveendran, R. (2012). Measurement of invasive blood pressure in rats. Journal of Pharmacology & Pharmacotherapeutics, 3, 172.","journal-title":"Journal of Pharmacology & Pharmacotherapeutics"},{"key":"9685_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/08977194.2020.1735382","volume":"37","author":"M Zarin","year":"2019","unstructured":"Zarin, M., Karbalaei, N., Keshtgar, S., & Nemati, M. (2019). Platelet-rich plasma improves impaired glucose hemostasis, disrupted insulin secretion, and pancreatic oxidative stress in streptozotocin-induced diabetic rat. Growth Factors, 37, 226\u2013237.","journal-title":"Growth Factors"},{"key":"9685_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.carpath.2008.10.015","volume":"19","author":"C M\u00fchlfeld","year":"2010","unstructured":"M\u00fchlfeld, C., Nyengaard, J. R., & Mayhew, T. M. (2010). A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovascular Pathology, 19, 65\u201382.","journal-title":"Cardiovascular Pathology"},{"key":"9685_CR28","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1002\/fsn3.1210","volume":"7","author":"Z Jafarinezhad","year":"2019","unstructured":"Jafarinezhad, Z., Rafati, A., Ketabchi, F., Noorafshan, A., & Karbalay-Doust, S. (2019). Cardioprotective effects of curcumin and carvacrol in doxorubicin-treated rats: Stereological study. Food Science & Nutrition, 7, 3581\u20133588.","journal-title":"Food Science & Nutrition"},{"key":"9685_CR29","first-page":"72","volume":"28","author":"YQ Liu","year":"2015","unstructured":"Liu, Y. Q., Gao, Y. B., Dong, J., Yao, B. W., Zhao, L., & Peng, R. Y. (2015). Pathological changes in the sinoatrial node tissues of rats caused by pulsed microwave exposure. Biomedical and Environmental Sciences: BES, 28, 72\u201375.","journal-title":"Biomedical and Environmental Sciences: BES"},{"key":"9685_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/07420528.2018.1563900","volume":"36","author":"F Karimi","year":"2019","unstructured":"Karimi, F., Rafati, A., Noorafshan, A., Hosseini, L., & Karbalay-Doust, S. (2019). Sinoatrial node remodels in chronic sleep-restricted rats. Chronobiology International, 36, 510\u2013516.","journal-title":"Chronobiology International"},{"key":"9685_CR31","doi-asserted-by":"publisher","first-page":"052","DOI":"10.4172\/1948-5956.1000184","volume":"5","author":"MS Oliveira","year":"2013","unstructured":"Oliveira, M. S., Melo, M. B., Carvalho, J. L., Melo, I. M., Lavor, M. S., Gomes, D. A., de Goes, A. M., & Melo, M. M. (2013). Doxorubicin cardiotoxicity and cardiac function improvement after stem cell therapy diagnosed by strain echocardiography. Journal of Cancer Science & Therapy, 5, 052.","journal-title":"Journal of Cancer Science & Therapy"},{"key":"9685_CR32","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/1947601911436199","volume":"2","author":"M Lu","year":"2011","unstructured":"Lu, M., Merali, S., Gordon, R., Jiang, J., Li, Y., Mandeli, J., Duan, X., Fallon, J., & Holland, J. F. (2011). Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice. Genes & Cancer, 2, 985\u2013992.","journal-title":"Genes & Cancer"},{"key":"9685_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0971-6580.97218","volume":"19","author":"SL Shah","year":"2012","unstructured":"Shah, S. L., Mali, V. R., Zambare, G. N., & Bodhankar, S. L. (2012). Cardioprotective activity of methanol extract of fruit of Trichosanthes cucumerina on doxorubicin-induced cardiotoxicity in Wistar rats. Toxicology International, 19, 167.","journal-title":"Toxicology International"},{"key":"9685_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8863789","volume":"2021","author":"R Carrasco","year":"2021","unstructured":"Carrasco, R., Castillo, R. L., Gormaz, J. G., Carrillo, M., & Thavendiranathan, P. (2021). Role of oxidative stress in the mechanisms of anthracycline-induced cardiotoxicity: Effects of preventive strategies. Oxidative Medicine and Cellular Longevity, 2021, 1\u201316.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"9685_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00005344-198401000-00028","volume":"6","author":"R Jensen","year":"1984","unstructured":"Jensen, R., Acton, E., & Peters, J. (1984). Doxorubicin cardiotoxicity in the rat: Comparison of electrocardiogram, transmembrane potential, and structural effects. Journal of Cardiovascular Pharmacology, 6, 186\u2013200.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9685_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00005344-200001000-00013","volume":"35","author":"R Cirillo","year":"2000","unstructured":"Cirillo, R., Sacco, G., Venturella, S., Brightwell, J., Giachetti, A., & Manzini, S. (2000). Comparison of doxorubicin-and MEN 10755-induced long-term progressive cardiotoxicity in the rat. Journal of Cardiovascular Pharmacology, 35, 100\u2013108.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9685_CR37","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00726-019-02801-7","volume":"51","author":"V\u00d6 Bar\u0131\u015f","year":"2019","unstructured":"Bar\u0131\u015f, V. \u00d6., Gedikli, E., Yersal, N., M\u00fcft\u00fco\u011flu, S., & Erdem, A. (2019). Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: Echocardiographical and histological findings. Amino Acids, 51, 1649\u20131655.","journal-title":"Amino Acids"},{"key":"9685_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.taap.2014.10.006","volume":"281","author":"VG Desai","year":"2014","unstructured":"Desai, V. G., Kwekel, J. C., Vijay, V., Moland, C. L., Herman, E. H., Lee, T., Han, T., Lewis, S. M., Davis, K. J., & Muskhelishvili, L. (2014). Early biomarkers of doxorubicin-induced heart injury in a mouse model. Toxicology and Applied Pharmacology, 281, 221\u2013229.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9685_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10557-007-6052-0","volume":"21","author":"X Chen","year":"2007","unstructured":"Chen, X., Chen, Y., Bi, Y., Fu, N., Shan, C., Wang, S., Aslam, S., Wang, P., & Xu, J. (2007). Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy. Cardiovascular Drugs and Therapy, 21, 367\u2013374.","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"9685_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1742-7843.2007.00070.x","volume":"101","author":"AL Anjos Ferreira","year":"2007","unstructured":"Anjos Ferreira, A. L., Russell, R. M., Rocha, N., Placido Ladeira, M. S., Favero Salvadori, D. M., Oliveira Nascimento, M. C. M., Matsui, M., Carvalho, F. A., Tang, G., & Matsubara, L. S. (2007). Effect of lycopene on doxorubicin-induced cardiotoxicity: An echocardiographic, histological and morphometrical assessment. Basic & Clinical Pharmacology & Toxicology, 101, 16\u201324.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"9685_CR41","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/ehf2.13198","volume":"8","author":"M Nicol","year":"2021","unstructured":"Nicol, M., Sadoune, M., Polidano, E., Launay, J. M., Samuel, J. L., Azibani, F., & Cohen-Solal, A. (2021). Doxorubicin-induced and trastuzumab-induced cardiotoxicity in mice is not prevented by metoprolol. ESC Heart Failure, 8, 928\u2013937.","journal-title":"ESC Heart Failure"},{"key":"9685_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.rvsc.2012.07.027","volume":"94","author":"FN Gava","year":"2013","unstructured":"Gava, F. N., Zacch\u00e9, E., Ortiz, E. M., Champion, T., Bandarra, M. B., Vasconcelos, R. O., Barbosa, J. C., & Camacho, A. A. (2013). Doxorubicin induced dilated cardiomyopathy in a rabbit model: An update. Research in Veterinary Science, 94, 115\u2013121.","journal-title":"Research in Veterinary Science"},{"key":"9685_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1939-1676.1992.tb03156.x","volume":"6","author":"GE Mauldin","year":"1992","unstructured":"Mauldin, G. E., Fox, P. R., Patnaik, A. K., Bond, B. R., Mooney, S. C., & Matus, R. E. (1992). Doxorubicin-induced cardiotoxicosis clinical features in 32 DOGS. Journal of Veterinary Internal Medicine, 6, 82\u201388.","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"9685_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.yjmcc.2009.08.023","volume":"48","author":"J Yanni","year":"2010","unstructured":"Yanni, J., Tellez, J., Sutyagin, P., Boyett, M., & Dobrzynski, H. (2010). Structural remodelling of the sinoatrial node in obese old rats. Journal of Molecular and Cellular Cardiology, 48, 653\u2013662.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9685_CR45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.eupc.2004.03.011","volume":"6","author":"T-A Matsuyama","year":"2004","unstructured":"Matsuyama, T.-A., Inoue, S., Kobayashi, Y., Sakai, T., Saito, T., Katagiri, T., & Ota, H. (2004). Anatomical diversity and age-related histological changes in the human right atrial posterolateral wall. EP Europace, 6, 307\u2013315.","journal-title":"EP Europace"},{"key":"9685_CR46","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/oxfordjournals.eurheartj.a060792","volume":"16","author":"A Alings","year":"1995","unstructured":"Alings, A., Abbas, R., & Bouman, L. (1995). Age-related changes in structure and relative collagen content of the human and feline sinoatrial node: A comparative study. European Heart Journal, 16, 1655\u20131667.","journal-title":"European Heart Journal"},{"key":"9685_CR47","doi-asserted-by":"publisher","first-page":"1001041","DOI":"10.1371\/journal.pcbi.1001041","volume":"6","author":"RV Oren","year":"2010","unstructured":"Oren, R. V., & Clancy, C. E. (2010). Determinants of heterogeneity, excitation and conduction in the sinoatrial node: a model study. PLoS Computational Biology, 6, 1001041.","journal-title":"PLoS Computational Biology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-021-09685-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-021-09685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T12:29:48Z","timestamp":1675600188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-021-09685-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["9685"],"URL":"https:\/\/doi.org\/10.1007\/s12012-021-09685-8","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures were approved by the Medical and Research Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (Approval No. 16330520952001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}